Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Greco

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Biochimica Et Biophysica Acta|December 24, 2013
Allosteric modulators of human A2B adenosine receptorMaria Letizia Trincavelli, Chiara Giacomelli, Simona Daniele, et al.
Bioorganic & Medicinal Chemistry|November 13, 2018
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A<sub>1</sub> and A<sub>2B</sub> adenosine receptor subtypesElisabetta Barresi, Chiara Giacomelli, Simona Daniele, et al.
European Journal of Medicinal Chemistry|October 1, 2013
Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivativesSabrina Taliani, Maria Letizia Trincavelli, Barbara Cosimelli, et al.
Journal of Medicinal Chemistry|November 1, 2002
Design, synthesis and biological evaluation of novel N-alkyl- and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs) as novel A(1) adenosine receptor antagonistsEttore Novellino, Enrico Abignente, Barbara Cosimelli, et al.
Journal of Medicinal Chemistry|February 14, 2008
Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonistsBarbara Cosimelli, Giovanni Greco, Marina Ehlardo, et al.
Advanced Healthcare Materials|September 11, 2020
A Novel Hybrid Silk Fibroin/Polyurethane Arteriovenous Graft for Hemodialysis: Proof-of-Concept Animal Study in an Ovine ModelStefania Adele Riboldi, Matteo Tozzi, Mara Bagardi, et al.
Journal of Medicinal Chemistry|January 19, 2007
New fluorescent 2-phenylindolglyoxylamide derivatives as probes targeting the peripheral-type benzodiazepine receptor: design, synthesis, and biological evaluationSabrina Taliani, Francesca Simorini, Valentina Sergianni, et al.
Chirality|April 21, 2016
Enantiomeric 4-Acylamino-6-alkyloxy-2 Alkylthiopyrimidines As Potential A3 Adenosine Receptor Antagonists: HPLC Chiral Resolution and Absolute Configuration Assignment by a Full Set of Chiroptical SpectroscopyDaniela Rossi, Rita Nasti, Annamaria Marra, et al.
Minerva Medica|July 3, 2018
Addiction disorders: a need for change. Proposal for a new management. Position paper of SIA, Italian Society on AlcoholGianni Testino, Luigi C Bottaro, Valentino Patussi, et al.
Journal of Medicinal Chemistry|April 14, 2006
Refinement of the benzodiazepine receptor site topology by structure-activity relationships of new N-(heteroarylmethyl)indol-3-ylglyoxylamidesGiampaolo Primofiore, Federico Da Settimo, Anna Maria Marini, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta|December 24, 2013
Allosteric modulators of human A2B adenosine receptorMaria Letizia Trincavelli, Chiara Giacomelli, Simona Daniele, et al.
Bioorganic & Medicinal Chemistry|November 13, 2018
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A<sub>1</sub> and A<sub>2B</sub> adenosine receptor subtypesElisabetta Barresi, Chiara Giacomelli, Simona Daniele, et al.
European Journal of Medicinal Chemistry|October 1, 2013
Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivativesSabrina Taliani, Maria Letizia Trincavelli, Barbara Cosimelli, et al.
Journal of Medicinal Chemistry|November 1, 2002
Design, synthesis and biological evaluation of novel N-alkyl- and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs) as novel A(1) adenosine receptor antagonistsEttore Novellino, Enrico Abignente, Barbara Cosimelli, et al.
Journal of Medicinal Chemistry|February 14, 2008
Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonistsBarbara Cosimelli, Giovanni Greco, Marina Ehlardo, et al.
Advanced Healthcare Materials|September 11, 2020
A Novel Hybrid Silk Fibroin/Polyurethane Arteriovenous Graft for Hemodialysis: Proof-of-Concept Animal Study in an Ovine ModelStefania Adele Riboldi, Matteo Tozzi, Mara Bagardi, et al.
Journal of Medicinal Chemistry|January 19, 2007
New fluorescent 2-phenylindolglyoxylamide derivatives as probes targeting the peripheral-type benzodiazepine receptor: design, synthesis, and biological evaluationSabrina Taliani, Francesca Simorini, Valentina Sergianni, et al.
Chirality|April 21, 2016
Enantiomeric 4-Acylamino-6-alkyloxy-2 Alkylthiopyrimidines As Potential A3 Adenosine Receptor Antagonists: HPLC Chiral Resolution and Absolute Configuration Assignment by a Full Set of Chiroptical SpectroscopyDaniela Rossi, Rita Nasti, Annamaria Marra, et al.
Minerva Medica|July 3, 2018
Addiction disorders: a need for change. Proposal for a new management. Position paper of SIA, Italian Society on AlcoholGianni Testino, Luigi C Bottaro, Valentino Patussi, et al.
Journal of Medicinal Chemistry|April 14, 2006
Refinement of the benzodiazepine receptor site topology by structure-activity relationships of new N-(heteroarylmethyl)indol-3-ylglyoxylamidesGiampaolo Primofiore, Federico Da Settimo, Anna Maria Marini, et al.
Pageof 7